Diverse neurotoxicants target the differentiation of embryonic neural stem cells into neuronal and glial phenotypes.
The large number of compounds that needs to be tested for developmental neurotoxicity drives the need to establish in vitro models to evaluate specific neurotoxic endpoints. We used neural stem cells derived from rat neuroepithelium on embryonic day 14 to evaluate the impact of diverse toxicants on their ability to differentiate into glia and neurons: a glucocorticoid (dexamethasone), organophosphate insecticides (chlorpyrifos, diazinon, parathion), insecticides targeting the GABAAreceptor (dieldrin, fipronil), heavy metals (Ni2+, Ag+), nicotine and tobacco smoke extract. We found three broad groupings of effects. One diverse set of compounds, dexamethasone, the organophosphate pesticides, Ni2+and nicotine, suppressed expression of the glial phenotype while having little or no effect on the neuronal phenotype. The second pattern was restricted to the pesticides acting on GABAAreceptors. These compounds promoted the glial phenotype and suppressed the neuronal phenotype. Notably, the actions of compounds eliciting either of these differentiation patterns were clearly unrelated to deficits in cell numbers: dexamethasone, dieldrin and fipronil all reduced cell numbers, whereas organophosphates and Ni2+had no effect. The third pattern, shared by Ag+and tobacco smoke extract, clearly delineated cytotoxicity, characterized by major cell loss with suppression of differentiation into both glial and neuronal phenotypes; but here again, there was some selectivity in that glia were suppressed more than neurons. Our results, from this survey with diverse compounds, point to convergence of neurotoxicant effects on a specific "decision node" that controls the emergence of neurons and glia from neural stem cells.
Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: t.slotkin@duke.edu.
Theodore A
TA
Slotkin
Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Samantha
S
Skavicus
Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Jennifer
J
Card
Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
Edward D
ED
Levin
Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Frederic J
FJ
Seidler
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects*; D003907:Dexamethasone / Q000633:toxicity; D053595:Embryonic Stem Cells / Q000166:cytology / Q000187:drug effects*; D005260:Female; D007306:Insecticides / Q000633:toxicity; D058953:Neural Stem Cells / Q000187:drug effects* / Q000473:pathology; D009457:Neuroglia / Q000187:drug effects* / Q000473:pathology; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D020258:Neurotoxicity Syndromes / Q000473:pathology*; D009498:Neurotoxins / Q000633:toxicity*; D009532:Nickel / Q000633:toxicity; D009538:Nicotine / Q000633:toxicity; D011247:Pregnancy; D061251:Primary Cell Culture; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects; D014028:Tobacco Smoke Pollution / Q000009:adverse effects
D007306:Insecticides; D009498:Neurotoxins; D011963:Receptors, GABA-A; D014028:Tobacco Smoke Pollution; D009538:Nicotine; D009532:Nickel; D003907:Dexamethasone
Dexamethasone; Insecticides; Metals; Neural stem cells; Nicotine; Tobacco smoke